InvestorsHub Logo

staccani

03/12/18 2:01 AM

#1777 RE: Lunacy_John Galt #1775

and do you think it would be very difficult to know how the patients are doing and if they are taking the drug of the placebo? This is a trial including 60 patients. The pharmacists in the hospitals would know for instance who is taking the drug and who is not

Inoviorulez

03/15/18 8:12 PM

#1796 RE: Lunacy_John Galt #1775

Well, the POLT trial had an interim analysis done by an IDMC and recommended the trial to completion back in 2015. They got to see initial results of mechanism of action.

http://ir.conatuspharma.com/news-releases/news-release-details/conatus-announces-initial-baseline-data-phase-2b-polt-hcv-svr